2016-15644. Submission for OMB Review; 30-Day Comment Request; Population Assessment of Tobacco and Health (PATH) Study-Fourth Wave of Data Collection  

  • Start Preamble

    AGENCY:

    National Institute of Health, HHS.

    SUMMARY:

    Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information Start Printed Page 43218collection was previously published in the Federal Register on April 15, 2016, pages 22290—22291 and allowed 60-days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number.

    Direct Comments To OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, OIRA_Submission@omb.eop.gov or by fax to (202) 395-6974, Attention: NIH Desk Officer.

    Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    To obtain a copy of the data collection plans and instruments, submit comments in writing or request more information on the proposed project, contact: Kevin P. Conway, Ph.D., Deputy Director, Division of Epidemiology, Services, and Prevention Research, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 5185; or call non-toll-free number (301) 443-8755; or Email your request, including your address to: PATHprojectofficer@mail.nih.gov. Formal requests for additional plans and instruments must be requested in writing.

    Proposed Collection: Population Assessment of Tobacco and Health (PATH) Study—Fourth Wave of Data Collection (NIDA), 0925-0664, expiration date 8/31/2018—REVISION—NIDA, NIH, in partnership with the Food and Drug Administration (FDA).

    Need and Use of Information Collection: This is a revision request (OMB number 0925-0664, expiration date 8/31/2018) for the Population Assessment of Tobacco and Health (PATH) Study to conduct the fourth wave of data collection. The PATH Study is a large national longitudinal cohort study on tobacco use behavior and health among the U.S. household population of adults age 18 and older and youth ages 12 to 17. On an annual basis, the PATH Study conducts interviews with and collects biospecimens from adults and youth to help inform the development, implementation, and evaluation of tobacco-product regulations by FDA in meeting its mission under the Family Smoking Prevention and Tobacco Control Act (TCA) to regulate tobacco products, including tobacco-product advertising, labeling, marketing, constituents, ingredients, and additives. The longitudinal design of the PATH Study provides it with the capacity to measure and report within-person changes and between-person differences in tobacco product use behaviors and health effects within the cohort over time. These data will help to inform regulatory decisions and actions by FDA and FDA's evaluations of associations between its regulations and tobacco use behaviors and health indicators in the population.

    OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 94,798.

    Estimated Annualized Burden Hours

    Form nameType of respondentNumber of respondentsNumber of responses per respondentAverage burden per response (in hours)Total annual burden hours
    1. Household ScreenerHouseholds48,018114/6011,204
    2. Individual ScreenerAdults—New adults9,15216/60915
    3. Extended InterviewAdults—New adults and Wave 1 youth respondents who age up to adult cohort at Wave 410,737168/6012,169
    4. Extended InterviewAdults—Adult respondents at previous wave23,4141123,414
    5. Parent InterviewAdults—Parents of new youth and parents of shadow youth who age up to youth cohort at Wave 46,561119/602,078
    6. Parent InterviewAdults—Parents of youth respondents at previous wave8,800116/602,347
    7. Extended InterviewYouth—New youth and shadow youth who age up to youth cohort at Wave 46,432145/604,824
    8. Extended InterviewYouth—Youth respondents at previous wave8,627135/605,032
    9. Tobacco Use FormAdults23,13315/601,928
    10. Tobacco Use FormYouth10,23915/60853
    11. Shadow Youth Only ScreenerHouseholds41,20715/603,434
    12. Verification InterviewAdults33,88912/601,130
    13. Validation InterviewAdults30114/6020
    14. Biospecimen Collection: BloodAdults—New adults and Wave 1 youth respondents who age up to adult cohort at Wave 44,832118/601,450
    15. Biospecimen Collection: UrineAdults18,301110/603,050
    16. Biospecimen Collection: UrineYouth10,239110/601,707
    17. Follow-up/Tracking Participant Information FormAdults34,15128/609,107
    18. Follow-up/Tracking Participant Information Form for Youth (completed by parents)Adults—Parents of youth respondents15,05928/604,016
    Start Printed Page 43219
    19. Follow-up/Tracking Participant Information Form for sample shadow youth (completed by parents)Adults—Parents of shadow youth4,68428/601,249
    20. Consent for Extended InterviewAdults—New adults and Wave 1 youth respondents who age up to adult cohort at Wave 413,98414/60932
    21. Parent Permission and Consent for Parent InterviewAdults—Parents of new youth and parents of Shadow youth who age up to youth cohort at Wave 47,65715/60638
    22. Assent for Extended InterviewYouth—New youth and shadow youth who age up to youth cohort at Wave 47,65713/60383
    23. Consent for Biological SamplesAdults—New adults and Wave 1 youth respondents who age up to adult cohort at Wave 410,73715/60895
    24. Parent permission for urine collectionAdults—Parents of youth respondents at previous wave15,36013/60768
    25. Assent for urine collectionYouth15,05915/601,255
    Total388,229442,12394,798
    Start Signature

    Dated: June 27, 2016.

    Genevieve deAlmeida,

    Project Clearance Liaison, National Institute on Drug Abuse, NIH.

    End Signature End Further Info End Preamble

    [FR Doc. 2016-15644 Filed 6-30-16; 8:45 am]

    BILLING CODE 4140-01-P

Document Information

Published:
07/01/2016
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
2016-15644
Dates:
Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication.
Pages:
43217-43219 (3 pages)
PDF File:
2016-15644.Pdf